Afatinib use in non-small cell lung cancer previously sensitive to epidermal growth factor receptor inhibitors: The United Kingdom Named Patient Programme.
Saved in:
| Title: | Afatinib use in non-small cell lung cancer previously sensitive to epidermal growth factor receptor inhibitors: The United Kingdom Named Patient Programme. |
|---|---|
| Authors: | Khan, F.1, Ottensmeier, C.2, Popat, S.3, Dua, D.4, Dorey, N.5, Ellis, S.6, Szabo, M.2, Upadhyay, S.7, Califano, R.8, Chan, S.9, Lee, L.8, Ali, C.W.10, Nicolson, M.11, Bates, A.T.2, Button, M.12, Chaudhuri, A.13, Mulvenna, P.14, Shaw, H.M.15, Danson, S.J.1 s.danson@sheffield.ac.uk |
| Source: | European Journal of Cancer. Jul2014, Vol. 50 Issue 10, p1717-1721. 5p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
